215 related articles for article (PubMed ID: 7151278)
1. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.
Ichinose M; Miki K; Furihata C; Kageyama T; Hayashi R; Niwa H; Oka H; Matsushima T; Takahashi K
Clin Chim Acta; 1982 Dec; 126(2):183-91. PubMed ID: 7151278
[TBL] [Abstract][Full Text] [Related]
2. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
Samloff IM; Liebman WM; Panitch NM
Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Huang SC; Miki K; Furihata C; Ichinose M; Shimizu A; Oka H
Clin Chim Acta; 1988 Jun; 175(1):37-50. PubMed ID: 3168282
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
Samloff IM; Stemmermann GN; Heilbrun LK; Nomura A
Gastroenterology; 1986 Mar; 90(3):570-6. PubMed ID: 3943688
[TBL] [Abstract][Full Text] [Related]
5. Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients.
Plebani M; Di Mario F; Vianello F; Giordano A; Masiero M; Lazzaretto M; Farini R; Ceriotti G; Naccarato R
Clin Biochem; 1983 Feb; 16(1):20-2. PubMed ID: 6861334
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of serum group I and II pepsinogens (PG I and PG II) by radioimmunoassay (RIA) in normal controls and patients with various disorders].
Miki K; Ichinose M; Furihata C; Kageyama T; Niwa H; Oka H; Matsushima T; Takahashi K
Nihon Shokakibyo Gakkai Zasshi; 1982 Nov; 79(11):2071-9. PubMed ID: 7161923
[No Abstract] [Full Text] [Related]
7. Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
Wu MS; Wang HP; Wang JT; Wang TH; Lin JT
J Gastroenterol Hepatol; 1995; 10(4):401-4. PubMed ID: 8527705
[TBL] [Abstract][Full Text] [Related]
8. [Study of serum pepsinogen fractions in patients with duodenal ulcer].
Urcan S; Fodor O; Abrudan O; Popescu S
Stud Cercet Med Interna; 1973; 14(6):519-23. PubMed ID: 4766833
[No Abstract] [Full Text] [Related]
9. Pepsinogens, pepsins, and peptic ulcer.
Samloff IM; Taggart RT
Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
[TBL] [Abstract][Full Text] [Related]
10. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer.
Matsukura N; Onda M; Tokunaga A; Fujita I; Okuda T; Mizutani T; Kyono S; Yamashita K
J Clin Gastroenterol; 1993; 17 Suppl 1():S146-50. PubMed ID: 8283010
[TBL] [Abstract][Full Text] [Related]
11. Serum group I pepsinogen levels in patients with peptic ulcer and normal subjects.
Nakanome C; Akai H; Goto Y
Tohoku J Exp Med; 1983 Feb; 139(2):151-8. PubMed ID: 6404006
[TBL] [Abstract][Full Text] [Related]
12. [24-h serum levels of gastrin and pepsinogen in peptic ulcer disease].
Mazzetti di Pietralata M; Carbonetti M; De Nicola CC; Giangregorio G; Leonardi C; Monetti D; Brandimarte G; Pomes M; Marcianò M; Cugini P
Recenti Prog Med; 1987 Jan; 78(1):26-8. PubMed ID: 3589117
[No Abstract] [Full Text] [Related]
13. Serum group I pepsinogen (PG I) levels and their changes in the healing process of the ulcer in patients with and without unoperated recurrent ulcer.
Nakanome C; Yamazaki H; Tanno N; Sasaki M; Sato W; Hanada M; Moriai N; Komatsu K
Tohoku J Exp Med; 1984 Jun; 143(2):239-48. PubMed ID: 6474453
[TBL] [Abstract][Full Text] [Related]
14. The effect of vagotomy and antrectomy on serum pepsinogens I and II.
Peetsalu A; Tamm A; Härkönen M; Varis K; Sipponen P; Karonen SL; Väli T; Villako K
Scand J Gastroenterol; 1990 May; 25(5):455-61. PubMed ID: 2359972
[TBL] [Abstract][Full Text] [Related]
15. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
[TBL] [Abstract][Full Text] [Related]
16. Actual role of pepsinogen group I in the study of upper gastrointestinal diseases.
Plebani M; Di Mario F; Vianello F; Farini R; Piccoli A; Lazzaretto L; Perobelli L; Naccarato R; Burlina A
Clin Biochem; 1983 Oct; 16(5):310-2. PubMed ID: 6652888
[TBL] [Abstract][Full Text] [Related]
17. [Serum pepsinogen I in gastroduodenal pathology].
Perasso A; Testino G
Recenti Prog Med; 1991 Feb; 82(2):86-90. PubMed ID: 2034875
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of determining pepsinogen I].
Griessen M; Male PJ; Infante F; Jodry H; Loizeau E
Schweiz Med Wochenschr; 1984 Dec; 114(49):1849-51. PubMed ID: 6515384
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of trefoil factor 1 protein and serum pepsinogen in benign and malignant gastric ulcers].
Yang J; Li CX; Dai YY; Peng F; Weng XM; Ji MX
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1540-3. PubMed ID: 22944057
[TBL] [Abstract][Full Text] [Related]
20. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1975 Dec; 69(6):1196-200. PubMed ID: 1193320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
